Very high resistance to amoxicillin in Streptococcus pneumoniae: an epidemiological fact or a technical issue?

M-T Camacho1, J Casal, L Aguilar

  • 1Spanish Reference Pneumococcal Laboratory, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Ctra. Majadahonda-Pozuelo Km. 2, 28220 Majadahonda, Madrid.

Insights

Reproducibility of high amoxicillin minimum inhibitory concentrations (MIC(AMX)) in Streptococcus pneumoniae is low. Retesting revealed significant shifts in MIC(AMX) values, especially with microdilution methods.

Area of Science:

  • Microbiology
  • Antimicrobial Resistance
  • Clinical Diagnostics

Background:

  • High amoxicillin minimum inhibitory concentrations (MIC(AMX)) in Streptococcus pneumoniae can impact treatment efficacy.
  • Accurate determination of MIC(AMX) is crucial for guiding antibiotic therapy and monitoring resistance trends.

Purpose of the Study:

  • To assess the reproducibility of high amoxicillin minimum inhibitory concentrations (MIC(AMX)) for Streptococcus pneumoniae.
  • To compare the reproducibility of agar dilution and microdilution methods for determining MIC(AMX).

Main Methods:

  • Retesting of Streptococcus pneumoniae isolates with previously determined high MIC(AMX) (16 µg/ml and 8 µg/ml) using both agar dilution and microdilution methods.
  • Testing followed NCCLS guidelines with standard and 2 µg/ml dilution steps.
  • Multiple retests (10 times) were performed to evaluate reproducibility.

Main Results:

  • A significant shift towards higher MIC(AMX) values was observed with microdilution compared to agar dilution (p<0.05).
  • Routine MIC(AMX) of 16 µg/ml was not confirmed by agar dilution in any retested strain.
  • Microdilution confirmed the high MIC(AMX) in 6 strains, with modal values of 10 µg/ml and 14 µg/ml using 2 µg/ml steps.

Conclusions:

  • There is low reproducibility for the highest MIC(AMX) values in Streptococcus pneumoniae.
  • Microdilution methods may show a higher tendency towards elevated MIC(AMX) values compared to agar dilution.
  • Standardized methods and careful interpretation are essential for reliable MIC(AMX) determination.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...